# Koninklijke Philips N.V. NY Registry Shares

> Clarifo company profile — qualitative business description generated from
> the company's filings. Financial statements, charts and ratios are
> available on Clarifo (https://www.clarifo.com/en/companies/Koninklijke Philips N.V. NY Registry Shares).

## Overview

Koninklijke Philips N.V. is a Dutch health technology company organized around professional healthcare systems and personal health products. Its business spans diagnostic imaging, ultrasound, image-guided therapy, monitoring, enterprise informatics, and consumer health solutions sold through a global direct and indirect network.

## Products & services

• Diagnostic imaging systems
• Ultrasound systems
• Image-guided therapy platforms
• Patient monitoring and enterprise informatics
• Personal health products
• Connected care solutions

- **Diagnostic Imaging** (30%) — Imaging equipment and related systems used in hospital diagnostics.
- **Connected Care** (25%) — Patient monitoring, informatics, and clinical workflow solutions for care settings.
- **Ultrasound** (15%) — Ultrasound systems used for diagnostic and procedural imaging.
- **Image-Guided Therapy** (15%) — Interventional systems and tools used during minimally invasive procedures.
- **Personal Health** (15%) — Consumer health and wellness products for home use.

- Diagnostic imaging systems
- Ultrasound systems
- Image-guided therapy platforms
- Patient monitoring and enterprise informatics
- Personal health products
- Connected care solutions

## Customers

Philips sells primarily to hospitals, health systems, and other healthcare providers that buy capital equipment, software, and service contracts for diagnosis and treatment. It also serves consumers through personal health products used in the home. Buying decisions are driven by clinical performance, installed-base compatibility, workflow integration, and service support.

- **Hospitals and health systems** (primary) — Buy imaging, monitoring, and therapy systems for diagnostic and treatment workflows.
- **Physicians and clinical departments** (primary) — Use ultrasound, image-guided therapy, and monitoring tools for patient care.
- **Healthcare IT and operations teams** (secondary) — Buy enterprise informatics and integration tools to manage care data.
- **Consumers** (secondary) — Buy personal health products for home use and wellness.

- Hospitals and health systems buying imaging and monitoring equipment
- Clinicians and departments needing workflow-integrated clinical systems
- Healthcare providers purchasing software and informatics tools
- Consumers buying home-use personal health products
- Institutions seeking service, installation, and lifecycle support

## Geography

Philips operates globally, with sales and services in more than 100 countries and headquarters in the Netherlands. Europe, North America, and Asia are key markets because hospital spending, installed-base service, and consumer health demand are spread across those regions.

- **Europe** — Europe is a core market and headquarters region, but no revenue split was disclosed.
- **North America** — North America is a major market for imaging, monitoring, and therapy systems.
- **Asia-Pacific** — Asia-Pacific includes both mature and emerging healthcare markets.

- Global sales and service footprint across more than 100 countries
- Headquartered in the Netherlands with management and reporting in Europe
- North America is important for large healthcare equipment demand
- Europe contributes meaningful hospital and consumer health demand
- Asia supports long-term growth in healthcare infrastructure

## Strategy

Philips is focused on combining clinical technologies, software, and service to improve care delivery across the hospital and home. Its strategy centers on innovation in diagnostic imaging, monitoring, and connected care, while using its installed base and global service network to deepen customer relationships.

- **Clinical innovation in core hospital categories** (medium-term) — Keeps Philips differentiated in large-ticket medical technology purchases.
- **Connected care and informatics** (medium-term) — Links devices, data, and workflow across the care continuum.
- **Service and installed-base monetization** (short-term) — Healthcare customers need lifecycle support, upgrades, and integration.
- **Consumer health portfolio** (long-term) — Provides exposure to home-use health demand beyond hospitals.

- Invest in clinical innovation across imaging, monitoring, and therapy
- Expand software and enterprise informatics around installed equipment
- Use service and recurring support to strengthen customer relationships
- Broaden personal health offerings for home and consumer use
- Maintain a global footprint to serve diverse healthcare systems

## Risks

Philips faces healthcare-equipment cycle risk, because hospital spending and large order timing can move demand between quarters and regions. It is also exposed to regulatory, product quality, reimbursement, and technology-transition risks that are common in medical devices and healthcare IT.

- **Large-order timing and capital spending cycles** [medium] — Imaging and monitoring systems are high-value purchases that can shift between periods.
- **Regulatory and product compliance risk** [high] — Medical devices require approvals, quality control, and post-market monitoring.
- **Technology obsolescence** [medium] — Clinical platforms must keep pace with imaging, software, and workflow advances.
- **Supply chain and trade exposure** [medium] — Global manufacturing and cross-border sales create sourcing and tariff risk.

- Hospital capital spending can delay large equipment orders
- Regulation and product compliance are critical in medical devices
- Technology shifts can make platforms obsolete
- Global operations expose Philips to trade and supply-chain issues
- Software and connected care products add cybersecurity and data risks

## Accounting

Philips reports in euros and uses IFRS judgment in areas such as estimates, provisions, and fair value measurements. Healthcare technology businesses also face revenue recognition complexity from system sales, service contracts, and software-enabled offerings, while quarterly comparability can be affected by large order timing and one-off items such as tariff-related benefits.

- **Revenue recognition** — Can shift sales between quarters and affect margin mix
- **Provisions and estimates** — Can materially affect operating profit and liabilities
- **Fair value and hedging** — Can create volatility in profit and OCI
- **Seasonality and order timing** — Can distort quarterly comparability

- Revenue recognition varies across equipment, service, and software contracts
- Estimates and judgments affect provisions and asset valuations
- Fair value and hedge accounting can move reported equity and profit
- Quarterly results can be distorted by large order timing
- Euro reporting creates foreign exchange translation effects

---

*Last updated: 2026-09-28T12:04:13.315439+00:00*